Stay updated on iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial
Sign up to get notified when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.

Latest updates to the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new build of the page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision label changed from v3.6.2 to v3.6.3, representing a small metadata update to the page. No content or functionality appears to be affected.SummaryDifference0.1%

- Check41 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, representing a small build update to the page. No content changes to the study details are reflected.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded a recruitment-status notice 'No longer looking for participants' and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study); updated the revision tag to v3.6.0 and adjusted the Intervention label in the Study Plan.SummaryDifference0.4%

- Check62 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This change reflects metadata or formatting adjustments rather than substantive content changes.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the study page, signaling a new version of the record. This is a metadata change and does not alter the study’s content.SummaryDifference0.1%

Stay in the know with updates to iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.